The True Meaning of Palliative Care: Maximizing Function in the Setting of Disability

Assessment of Needs

The development and advancement of treatment options have transformed HIV into a chronic disease, which results in an overall increase in the number of people with symptomatic HIV disease who require palliative care. Interventions for an aging population of people with HIV should take a person-centered approach, balancing different priorities and exploring various avenues for symptom relief. The purpose of this webinar is to explore the true meaning of palliative care, maximizing quality of life and function in the setting of disability, eg, pain, neurologic impairment, cardiac comorbidities, and other impairments.

Learning Objectives

At the end of this webinar, participants will be able to:

• Describe the role of palliative care in improving function and quality of life for people with HIV
• Describe the management of HIV-specific symptoms using novel interventions, such as cannabinoids, exercise and self-management interventions, and tailored cognitive-behavioral therapy for older people with HIV

Registration

Who Should Attend

This webinar is designed for clinical decision makers who are actively involved in HIV care and research, including physicians, physician assistants, nursing professionals, pharmacists, and other health care professionals.

Individual registration is required in order to receive CME credit or a certificate of participation.

Registration closes on Thursday, July 24, 2025, 10:30 AM (PT).

For more information or questions, please contact the registration department at registration@iasusa.org or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities. 

The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”

IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the slides prior to the presentation of educational content.

Presenter

Dr Robinson-Papp reported consulting or advisor fees from Eli Lilly and Company. (Updated April 29, 2025)

Moderator

Dr Saag reported no relevant financial relationships with ineligible companies (Updated March 20, 2025)

Planner/Reviewer

COW Board

The financial relationships of the COW Board can be found here: https://www.iasusa.org/activities/cases-on-the-web/about-cows/cow-webinars-editorial-board/